2-(7-chloro-1.8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-1H-isoindol-1-one,
pagoclone,
RP 62955,
Pagoclone,
133737-32-3,
133737-48-1,
RP-59037,
UNII-38VAG2SA33,
IP-456,
RP-62955,
2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one,
38VAG2SA33,
2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-3H-isoindol-1-one,
Pagoclone [USAN:INN],
CI-1043,
(+)-Pagoclone,
IP 456,
RP 59037,
RP 62955,
Pagoclone (USAN/INN),
AC1L2ZKA,
(+)-RP 59037,
MLS006010289,
SCHEMBL449997,
CHEMBL2104745,
SCHEMBL14336500,
EX-A896,
HIUPRQPBWVEQJJ-UHFFFAOYSA-N,
BCP28850,
MFCD00864700,
2-(7-Chloro-2-naphthyridin-1,8-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one,
AKOS015960516,
CI 1043,
CS-6427,
DB04903,
SB17133,
NCGC00386587-01,
CC-33450,
DA-45926,
SMR004701358,
HY-101665,
FT-0700167,
FT-0763408,
(+)-RP-59037,
D02616,
C-23668,
J-690132,
(+)-2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone,
(+)-2-(7-Chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)phthalimidine,
2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone,
Ethyl 3-({(4-chlorobenzyl)[(5-nitro-2-thienyl)methyl]amino}methyl)-1-pyrrolidinecarboxylate,
racemic-2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone,
1H-Isoindol-1-one, 2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-,
1H-Isoindol-1-one, 2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-, (+)-,
2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-1H-isoindol-1-one,
Bextra,
Panex,
Bextra (TN),
D0O0PY,
C23H22ClN3O2,
C23-H22-Cl-N3-O2,
CID131664,
(+)-2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-isoindolinone,
(+)-2-(7-Chloro-1,8-naph-thyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-1H-isoindol-1-one,